222 related articles for article (PubMed ID: 23733396)
1. Concise review: role of DEK in stem/progenitor cell biology.
Broxmeyer HE; Mor-Vaknin N; Kappes F; Legendre M; Saha AK; Ou X; O'Leary H; Capitano M; Cooper S; Markovitz DM
Stem Cells; 2013 Aug; 31(8):1447-53. PubMed ID: 23733396
[TBL] [Abstract][Full Text] [Related]
2. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
3. A role for intracellular and extracellular DEK in regulating hematopoiesis.
Capitano ML; Broxmeyer HE
Curr Opin Hematol; 2017 Jul; 24(4):300-306. PubMed ID: 28306668
[TBL] [Abstract][Full Text] [Related]
4. DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.
Broxmeyer HE; Kappes F; Mor-Vaknin N; Legendre M; Kinzfogl J; Cooper S; Hangoc G; Markovitz DM
Stem Cells Dev; 2012 Jun; 21(9):1449-54. PubMed ID: 21943234
[TBL] [Abstract][Full Text] [Related]
5. All hands on DEK.
Bodine DM
J Clin Invest; 2019 May; 129(6):2205-2206. PubMed ID: 31107244
[TBL] [Abstract][Full Text] [Related]
6. Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.
Serrano-Lopez J; Nattamai K; Pease NA; Shephard MS; Wellendorf AM; Sertorio M; Smith EA; Geiger H; Wells SI; Cancelas JA; Privette Vinnedge LM
Exp Hematol; 2018 Mar; 59():40-50.e3. PubMed ID: 29288703
[TBL] [Abstract][Full Text] [Related]
7. C/EBPα and DEK coordinately regulate myeloid differentiation.
Koleva RI; Ficarro SB; Radomska HS; Carrasco-Alfonso MJ; Alberta JA; Webber JT; Luckey CJ; Marcucci G; Tenen DG; Marto JA
Blood; 2012 May; 119(21):4878-88. PubMed ID: 22474248
[TBL] [Abstract][Full Text] [Related]
8. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.
Chen Z; Huo D; Li L; Liu Z; Li Z; Xu S; Huang Y; Wu W; Zhou C; Liu Y; Kuang M; Wu F; Li H; Qian P; Song G; Wu X; Chen J; Hou Y
J Exp Med; 2021 May; 218(5):. PubMed ID: 33755722
[TBL] [Abstract][Full Text] [Related]
9. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia.
Wilcher KE; Page ERH; Privette Vinnedge LM
Exp Hematol; 2023 Jul; 123():18-27. PubMed ID: 37172756
[TBL] [Abstract][Full Text] [Related]
10. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
[TBL] [Abstract][Full Text] [Related]
11. The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK.
Ageberg M; Gullberg U; Lindmark A
Haematologica; 2006 Feb; 91(2):268-9. PubMed ID: 16461319
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo.
Wise-Draper TM; Mintz-Cole RA; Morris TA; Simpson DS; Wikenheiser-Brokamp KA; Currier MA; Cripe TP; Grosveld GC; Wells SI
Cancer Res; 2009 Mar; 69(5):1792-9. PubMed ID: 19223548
[TBL] [Abstract][Full Text] [Related]
13. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
[TBL] [Abstract][Full Text] [Related]
14. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.
Privette Vinnedge LM; McClaine R; Wagh PK; Wikenheiser-Brokamp KA; Waltz SE; Wells SI
Oncogene; 2011 Jun; 30(24):2741-52. PubMed ID: 21317931
[TBL] [Abstract][Full Text] [Related]
15. Trim27 confers myeloid hematopoiesis competitiveness by up-regulating myeloid master genes.
Wang T; Xia C; Dong Y; Chen X; Wang J; Du J
J Leukoc Biol; 2018 Oct; 104(4):799-809. PubMed ID: 29897614
[TBL] [Abstract][Full Text] [Related]
16. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
[TBL] [Abstract][Full Text] [Related]
17. The human DEK oncogene regulates DNA damage response signaling and repair.
Kavanaugh GM; Wise-Draper TM; Morreale RJ; Morrison MA; Gole B; Schwemberger S; Tichy ED; Lu L; Babcock GF; Wells JM; Drissi R; Bissler JJ; Stambrook PJ; Andreassen PR; Wiesmüller L; Wells SI
Nucleic Acids Res; 2011 Sep; 39(17):7465-76. PubMed ID: 21653549
[TBL] [Abstract][Full Text] [Related]
18. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
19. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
Qin H; Malek S; Cowell JK; Ren M
Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
[TBL] [Abstract][Full Text] [Related]
20. The DEK nuclear autoantigen is a secreted chemotactic factor.
Mor-Vaknin N; Punturieri A; Sitwala K; Faulkner N; Legendre M; Khodadoust MS; Kappes F; Ruth JH; Koch A; Glass D; Petruzzelli L; Adams BS; Markovitz DM
Mol Cell Biol; 2006 Dec; 26(24):9484-96. PubMed ID: 17030615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
